MyoKardia Inc·4

Jan 3, 8:22 PM ET

McDowell Robert Scott 4

4 · MyoKardia Inc · Filed Jan 3, 2020

Insider Transaction Report

Form 4
Period: 2020-01-01
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2020-01-011,9253,850 total
    Common Stock (1,925 underlying)
  • Exercise/Conversion

    Common Stock

    2020-01-01+6,8758,033 total
  • Exercise/Conversion

    Restricted Stock Units

    2020-01-014,95014,850 total
    Common Stock (4,950 underlying)
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer.
  • [F3]Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION